Summa Health appoints new leader for cancer institute
Dr. Gilbert Padula
AKRON – Summa Health has named Dr. Gilbert Padula as its new medical director for the Summa Health Cancer Institute. Padula, who was also named the Vincent and Nancy DiGirolamo Endowed Chair in Oncology, begins in his new role Jan. 30.
Padula joins Summa Health from Grand Rapids, Mich., where he had been president of Grand Rapids Radiation Oncology at the Mercy Health Lacks Cancer Center since 2002. For the past three years, he also served as medical director for technology and innovation at the Lacks Cancer Center. While in Michigan, he was the principal investigator for the Cancer Research Consortium of West Michigan, which brought in, over five years, nearly $10 million to the community for cancer research.
“We are thrilled to welcome Dr. Padula to the Summa Health family,” said Dr. Vivian von Gruenigen, chief medical officer for the health system. “He brings a wealth of talent and expertise to our outstanding team of cancer professionals. We look forward to his leadership.”
A native of Rockledge, Fla., Padula received a Bachelor of Science degree from the University of Michigan in 1991. He then completed post-baccalaureate premedical studies at Columbia University before earning his medical degree from the Michigan State University College of Human Medicine. Padula completed his internship at St. Joseph Mercy Hospital in Ann Arbor, Mich., and his residency at Memorial Sloan Kettering Cancer Center in New York, N.Y.
Padula is widely published and has been an invited lecturer and speaker for many organizations across the state of Michigan. Throughout his career, he has received numerous honors and awards and has held leadership roles in many professional associations.
Padula joins Summa Health from Grand Rapids, Mich., where he had been president of Grand Rapids Radiation Oncology at the Mercy Health Lacks Cancer Center since 2002. For the past three years, he also served as medical director for technology and innovation at the Lacks Cancer Center. While in Michigan, he was the principal investigator for the Cancer Research Consortium of West Michigan, which brought in, over five years, nearly $10 million to the community for cancer research.
“We are thrilled to welcome Dr. Padula to the Summa Health family,” said Dr. Vivian von Gruenigen, chief medical officer for the health system. “He brings a wealth of talent and expertise to our outstanding team of cancer professionals. We look forward to his leadership.”
A native of Rockledge, Fla., Padula received a Bachelor of Science degree from the University of Michigan in 1991. He then completed post-baccalaureate premedical studies at Columbia University before earning his medical degree from the Michigan State University College of Human Medicine. Padula completed his internship at St. Joseph Mercy Hospital in Ann Arbor, Mich., and his residency at Memorial Sloan Kettering Cancer Center in New York, N.Y.
Padula is widely published and has been an invited lecturer and speaker for many organizations across the state of Michigan. Throughout his career, he has received numerous honors and awards and has held leadership roles in many professional associations.